-  - Изменение - Объем сделки Бид- Предложение- Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
210.1000EUR - 0
Оборот: 0.0000
-Величина цены спроса: - -Величина цены предложения: - 221.95 млрдEUR - -

Описание деятельности

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Founded in 1896, Roche has been making important contributions to global health for more than a century. Twenty-four medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy.
 

Правление & Наблюдательный совет

Исполнительный директор
Dr. Thomas Schinecker
Правление
Dr. Alan Hippe, Cristina A. Wilbur, Teresa Graham, Matt Sause , Claudia Bockstiegel, Prof. Dr. Hans Clevers, Dr. Levi Garraway, Silke Hornstein, Dr. Aviv Regev, Dr. James H. Sabry, Barbara Schadler
Наблюдательный совет
André Hoffmann, Anita Hauser, Bernard Poussot, Dr. Claudia Süssmuth Dyckerhoff, Dr. Patrick Frost, Dr. Severin Schwan, Prof. Dr. Richard Lifton, Dr. Mark Schneider, Dr. Jemilah Mahmood, Prof. Dr. Akiko Iwasaki, Dr. Joorg Duschmale
 

Данные компании

Имя: Roche Holding
Адрес: Grenzacherstraße 124,CH-4070 Basel
Телефон: +41-61-688-1111
Факс: -
E-mail: basel.webmaster@roche.com
Интернет: www.roche.com
Индустрия: Healthcare
Сектор: Pharmaceutical Industry
Подсектор: Pharmaceuticals
Конец финансового года: 31.12
Акции в свободном обращении: 88.00%
Дата IPO: 03.04.1995

Связи с инвесторами

Имя: Bruno Eschli
IR телефон: +41 (61) 687 5284
IR-факс: +41 (61) 691 0014
IR e-mail: investor.relations@roche.com

Календарь компании

CW 30 | 25.07.2024 Interim Report 2nd Quarter/6 Months
CW 43 | 23.10.2024 Interim Report 3rd Quarter/9 Months
 

Основные акционеры

Другие
 
99.65%
Fisher Asset Management, LLC
 
0.26%
Sound Shore Management, Inc.
 
0.03%
Saratoga Research & Investment Management
 
0.03%
Cullen Capital Management, LLC
 
0.02%
Boston Common Asset Management, LLC
 
0.01%